Koul, D., Wang, S., Wu, S., Saito, N., Zheng, S., Gao, F., . . . Yung, W. A. (2017). Preclinical therapeutic efficacy of a novel blood-brain barrier-penetrant dual PI3K/mTOR inhibitor with preferential response in PI3K/PTEN mutant glioma. Oncotarget.
Παραπομπή Chicago StyleKoul, Dimpy, et al. "Preclinical Therapeutic Efficacy of a Novel Blood-brain Barrier-penetrant Dual PI3K/mTOR Inhibitor With Preferential Response in PI3K/PTEN Mutant Glioma." Oncotarget 2017.
Παραπομπή MLAKoul, Dimpy, et al. "Preclinical Therapeutic Efficacy of a Novel Blood-brain Barrier-penetrant Dual PI3K/mTOR Inhibitor With Preferential Response in PI3K/PTEN Mutant Glioma." Oncotarget 2017.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.